Proteasom-Untereinheit beta Typ 9
Das PSMB9-Gen kodiert eine Komponente der Proteasomen, deren Mutationen zu Funktionsstörungen und damit zu autoinflammatorischen Prozessen führen können.
Gentests:
Klinisch |
Untersuchungsmethoden |
Familienuntersuchung |
Bearbeitungszeit |
5 Tage |
Probentyp |
genomische DNS |
Verknüpfte Erkrankungen:
Referenzen:
1. |
Brehm A et. al. (2015) Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.
|
2. |
Martinez CK et al. (1991) Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene.
|
3. |
Glynne R et al. (1991) A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC.
|
4. |
Kelly A et al. (1991) Second proteasome-related gene in the human MHC class II region.
|
5. |
Van Kaer L et al. (1994) Altered peptidase and viral-specific T cell response in LMP2 mutant mice.
|
6. |
Deng GY et al. (1995) Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies.
|
7. |
Akiyama K et al. (1994) cDNA cloning and interferon gamma down-regulation of proteasomal subunits X and Y.
|
8. |
Zhou P et al. (1993) Genomic organization and tissue expression of mouse proteasome gene Lmp-2.
|
9. |
Driscoll J et al. (1993) MHC-linked LMP gene products specifically alter peptidase activities of the proteasome.
|
10. |
Gaczynska M et al. (1993) Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.
|
11. |
None (2001) Meiotic recombination hot spots and cold spots.
|
12. |
Guillon H et al. (2002) An initiation site for meiotic crossing-over and gene conversion in the mouse.
|
Update: 14. August 2020